Drug Profile
TNF binding protein
Alternative Names: Recombinant tumour necrosis factor binding protein; rTNFbp; TNFbpLatest Information Update: 20 Mar 1997
Price :
$50
*
At a glance
- Originator Amgen
- Class
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 20 Mar 1997 Discontinued-II for Rheumatoid arthritis in USA (Unknown route)
- 15 Aug 1996 Phase-II clinical trials for Rheumatoid arthritis in USA (Unknown route)
- 28 Jun 1996 New profile